Fundraising Fox
/Companies
Sign in

Maxwell Biosciences

Austin, US · Delaware corporation · 4 known investors

Find your way into Maxwell Biosciences

Sign up to find every way you can get introduced to Maxwell Biosciences

  • Your email: who you already know at Maxwell Biosciences, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Maxwell Biosciences team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Maxwell Biosciences develops therapeutics aimed at treating infectious diseases. The company works with research and defense institutions on biodefense and antimicrobial-related work.

AI & Machine LearningBiotechHealthtechLongevity

Founders & leadership

JMJoshua McClure
Joshua McClureFounder
KMKate McKinley
Kate McKinleyBoard Director, Chair Investment Committee, Chair Compensation Committee
PT
Praveen TyleNamed on SEC filing
BR
Barbara R HolcombNamed on SEC filing
AB
Annelise BarronNamed on SEC filing

Investors · 4

Das & Co.listed by Das & Co.New York
Keiretsu Forumlisted by Keiretsu ForumSan Francisco East Bay · $250K – $2M

How we know: Keiretsu Forum's portfolio page · Not right? Tell us

LoftyInc Capitallisted by LoftyInc CapitalHouston

How we know: LoftyInc Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$10.9M disclosed across 1 of 4 rounds · 2021–2026

▶$25MofferedJul 2023 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua McClureExecutive Officer, Director, Promoter
  • Kate McKinleyDirector
  • Praveen TyleDirector
  • Barbara R HolcombDirector
  • Annelise BarronDirector
Offering amount
$25M
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.9MraisedApr 2022 · 96 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Praveen TyleDirector
  • Annelise BarronDirector
  • Theodore MoskovitzDirector
  • Christopher JohnsDirector
  • Joshua McClureExecutive Officer, Director
Offering amount
$14.8M
Amount sold
$10.9M
First sale
Oct 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as Maxwell Biosciences.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2021$256.5K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Maxwell Biosciences' Spinout SHU.ai Announces Closing of $1M Financing Roundfinance.yahoo.com · Aug 2026Maxwell Biosciences Announces Closing of $20M Financing Roundfinance.yahoo.com · Aug 2025Biotech Startup Maxwell Biosciences Selected to Present at the Angel Capital Association 2023 Summit — Maxwell Biosciencesmaxwellbiosciences.com · May 2023Maxwell Biosciences Announces the Appointment of Maxie McFarland, MBA, as Senior Vice President of Corporate Development and Investor Relations — Maxwell Biosciencesmaxwellbiosciences.com · Apr 2023Maxwell Biosciences Awarded “Most Promising” 2022 Life Sciences Company in Texas Competition — Maxwell Biosciencesmaxwellbiosciences.com · Feb 2022

Frequently asked questions

What does Maxwell Biosciences do?
Maxwell Biosciences develops therapeutics aimed at treating infectious diseases. The company works with research and defense institutions on biodefense and antimicrobial-related work.
Who founded Maxwell Biosciences?
Maxwell Biosciences was founded by Joshua McClure.
Who are Maxwell Biosciences's investors?
Maxwell Biosciences's investors include Capital Factory, Das & Co., Keiretsu Forum, LoftyInc Capital.
How much funding has Maxwell Biosciences raised?
Maxwell Biosciences has disclosed $10.9M raised across 1 of its 4 known rounds.
Where is Maxwell Biosciences headquartered?
Maxwell Biosciences is headquartered in Austin, US.